DEF: ParkerVision Sets Annual Meeting Date, Director Nominees

ParkerVision, Inc. has announced its 2026 Annual Meeting of Shareholders, scheduled for September 25, 2026, detailing director nominations and the ratification of its independent auditor.

Summary

• ParkerVision, Inc. is holding its 2026 Annual Meeting of Shareholders on September 25, 2026, virtually.
• Shareholders will vote on the election of two directors: Jeffrey L. Parker for Class I until 2029 and Anthony B. Bowers for Class II until 2027.
• The appointment of Frazier & Deeter, LLC as the independent registered public accounting firm for the year ending December 31, 2026, will also be ratified.
• The record date for determining eligible shareholders is July 29, 2026, with 148,226,874 shares of common stock outstanding.
• The filing details corporate governance practices, including leadership structure, director independence, and risk management oversight.
• Executive compensation for 2025 and 2024 is outlined, including base salaries, bonuses, and equity awards, with a focus on performance-based options.
• Information on stock ownership by major holders, directors, and executive officers is provided as of July 29, 2026.
• Related party transactions, including sales of stock and convertible notes involving director Lewis Titterton and patent legal services with a firm where director Robert Sterne is a partner, are disclosed.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily focused on procedural matters for the upcoming annual meeting rather than significant operational or financial updates. The re-nomination of directors and ratification of auditors are standard, with some positive notes on director compensation adjustments and executive option modifications.

Positives

• The company is holding its annual meeting, indicating ongoing operational and governance processes.
• Director Jeffrey L. Parker is nominated for re-election, providing continuity in leadership.
• Anthony B. Bowers is nominated to fill a vacancy, bringing new expertise to the board.
• The appointment of Frazier & Deeter, LLC as auditor is proposed for ratification, ensuring financial oversight.
• Director compensation is aligned with independent consultant recommendations, with awards valued around $80,000 for 2025 and $76,000 for 2026.
• Executive compensation includes performance-based stock options tied to patent enforcement actions, aligning management with a key company strategy.
• The company has a process for shareholder communications with the Board of Directors.

Negatives

• The company's net loss was $7,426,000 in 2025, indicating continued financial challenges.
• The pay versus performance disclosure shows a significant disconnect between compensation paid and net income, particularly in 2025.
• The company recorded a one-time charge of approximately $1.9 million in 2025 related to the modification of executive stock options.
• The company recorded a one-time charge of approximately $0.4 million in 2026 related to the modification of executive stock options.
• The company paid approximately $42,000 and $39,000 in 2025 and 2024, respectively, for patent-related legal services to Sterne, Kessler, Goldstein & Fox, PLLC, where director Robert Sterne is a partner.

Risks

• The company's financial performance is heavily reliant on the success of its patent enforcement actions, as indicated by performance-based executive compensation.
• The company has experienced net losses, suggesting ongoing financial instability.
• The modification of executive stock options, while extending expiration dates, resulted in significant one-time charges to share-based compensation.
• The company's stock is traded on the OTCQB Venture Market, which may imply lower liquidity and higher volatility compared to major exchanges.

Future Outlook

The filing does not contain specific forward-looking financial guidance. It outlines the agenda for the upcoming annual meeting, including director elections and auditor ratification, and provides details on executive and director compensation structures and historical related party transactions.

Management Comments

• The Board believes that combining the roles of Chief Executive Officer and Chairman of the Board promotes leadership and direction for the Board and for executive management, as well as allowing for a single, clear focus for the chain of command.
• Management periodically reports to the Board about the identification, assessment and management of critical risks and managements risk mitigation strategies.
• The compensation committee strives to create incentives that encourage behavior consistent with our business strategy, without encouraging undue risk-taking.
• The Board believes that Mr. Parker is uniquely qualified through his experience and expertise to be the person who generally sets the agenda for, and leads discussions of, issues relating to the implementation of our strategic plan.
• The bonuses awarded in January 2025 were in recognition of the officers' significant contribution to our strategic initiatives, including Mr. Parker's leadership in overseeing our patent litigation efforts and supporting our financial stability and Ms. French's role in maintaining compliance with regulatory requirements and reducing costs associated with outside professional services.

Industry Context

StockSavvy.ai notes that ParkerVision operates in a sector where intellectual property and patent litigation are significant strategic and financial factors, as evidenced by the performance-based compensation tied to patent enforcement actions. This is common in technology companies with strong IP portfolios.

Comparison to Industry Standards

• Director compensation is benchmarked against peer groups, with awards generally valued around $80,000, aligning with independent consultant recommendations.
• Executive base salaries for Mr. Parker and Ms. French were set below the 50th percentile when compared to a similarly sized peer group developed by Alliant.
• The company's reliance on patent enforcement actions for revenue generation is a specific strategy, and its success relative to industry peers in monetizing IP is not detailed in this filing.

Management Changes

Corporate Governance

Legal Proceedings

• The company's patent litigation efforts are a significant focus, influencing executive compensation and strategic initiatives.

Related Party Transactions

• On November 17, 2025, the company sold 4,761,905 shares of common stock at $0.21 per share to Lewis Titterton for $1,000,000.
• Lewis Titterton previously purchased convertible notes totaling $425,000, with various conversion prices and maturity dates; these notes were either repaid or converted into common stock by December 31, 2025.
• Convertible notes held by Paul Rosenbaum were amended to defer interest payments and subsequently converted into common stock.
• The company paid approximately $42,000 and $39,000 in 2025 and 2024, respectively, for patent-related legal services to Sterne, Kessler, Goldstein & Fox, PLLC, where Robert Sterne is a partner.
• The company paid approximately $150,000 in both 2025 and 2024 for principal and interest on a note payable to Sterne, Kessler, Goldstein & Fox, PLLC, with an outstanding balance of approximately $0.2 million at December 31, 2025.

Stakeholder Impact

• Shareholders will vote on director elections and auditor ratification, directly impacting corporate governance and oversight.
• Executive compensation, particularly performance-based options tied to patent enforcement, may influence management's focus and shareholder returns.
• Related party transactions, such as stock sales and legal services, are disclosed to ensure transparency for shareholders and other stakeholders.

Next Steps

• Shareholders will vote on the election of directors and the ratification of the independent auditor at the Annual Meeting.
• The company will hold its 2026 Annual Meeting of Shareholders on September 25, 2026.
• Shareholders wishing to submit proposals for the 2027 Annual Meeting must do so by April 13, 2027.

Key Dates

Recommendation

The filing is primarily procedural, outlining the annual meeting agenda and standard corporate governance disclosures. While there are no significant negative financial revelations, the company's continued reliance on patent litigation for revenue and past net losses suggest a cautious 'hold' approach pending clearer signs of sustainable operational growth or successful monetization of its IP portfolio.

Keywords

Annual Meeting, Director Election, Independent Auditor, Corporate Governance, Executive Compensation, Shareholder Proposals, Stock Ownership, Related Party Transactions